Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2022 inter alia to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we wish to intimate that a meeting of our Board of Directors of the Company will be held on Monday August 01 2022 inter alia to consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter ended June 30 2022.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
